Miro Sciences LtdASX: MSX

Manufacturing Milestone Achieved - TGA Inspection Completed

· Issued by Miro Sciences Ltd via ASX

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Miro Sciences Ltd has announced the completion of a significant manufacturing milestone with the Therapeutic Goods Administration inspection of its manufacturing partner, Q-Gen Cell Therapeutics, for its StemSmart™ product. The TGA inspection marks an important operational achievement as Miro Sciences progresses towards its clinical goals.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX: MSX ASX Announcement 12 November 2026 StemSmart™ Manufacturing Milestone Achieved with TGA Inspection Completed TGA Inspection is a major step towards the supply of StemSmart™ for Phase 2 clinical trial in Crohn’s disease Highlights: • TGA has completed its inspection of Q-Gen Cell...

Miro Sciences Ltd on 6ix

Earlier from Miro Sciences

All Miro Sciences news releases